iCP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female Subjects

NCT05740280 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped Closed by Sponsor for business reasons

Conditions

Healthy Volunteers

Interventions

DRUG: iCP-NI
DRUG: Placebo

Sponsor

Cellivery Therapeutics, Inc.

Collaborators

[object Object]